Journament

Keyword Connections - antiretroviral therapy Keywords

Connection Type	Connection
Journals	zhonghua liu xing bing xue za zhi = zhonghua liuxingbingxue zazhi BMC health services research HIV medicine Open forum infectious diseases Drug design, development and therapy journal of the international association of providers of aids care aids and behavior Journal of the International AIDS Society hiv/aids (auckland, nz) plastic and reconstructive surgery public health action pregnancy hypertension
Research Groups	No Research Group Connected
Bibliographies	[1] Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial. [2] Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. [3] Unearthing how, why, for whom and under what health system conditions the antiretroviral treatment adherence club intervention in South Africa works: A realist theory refining approach. [4] [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin]. [5] ART Adherence Among Malawian Youth Enrolled in Teen Clubs: A Retrospective Chart Review. [6] Fertility Intentions and Clinical Care Attendance Among Women Living with HIV in South Africa. [7] Associations Between Anxiety and Adherence to Antiretroviral Medications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. [8] Clinical and operational factors associated with low pediatric inpatient HIV testing coverage in Mozambique. [9] Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease [10] Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies [11] Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection [12] Early Mortality in Adults Initiating Antiretroviral Therapy (ART) in Low- and Middle-Income Countries (LMIC): A Systematic Review and Meta-Analysis [13] pacientes que rehúsan el tratamiento antirretroviral en el medio penitenciario patients who refuse antiretroviral treatment in prison [14] causes of t lymphocyte activation in hiv-infected patients coinfected with hepatitis c virus [15] raltegravir is the first hiv integrase inhibitor as part of antiretroviral treatment regimens [16] current treatment of hiv infection [17] experiência da adesão ao tratamento entre mulheres com vírus da imunodeficiência humana/ síndrome da imunodeficiência adquirida experiencia de la adhesión al tratamiento de mujeres con vih/sida hiv/aids treatment regimens adherence in women [18] effect of antiretroviral therapy on changes in the fertility intentions of human immunodeficiency virus-positive women in addis ababa, ethiopia: a prospective follow-up study [19] prevenção da transmissão vertical do hiv: atitude dos obstetras em salvador, brasil prevention of hiv vertical transmission: obstetricians'atitude in salvador, brasil [20] concordance between pharmacotherapeutic complexity calculated and perceived by hiv+ patients with antiretroviral treatment [21] second-line failure and first experience with third-line antiretroviral therapy in mumbai, india [22] new drug resistance mutations of reverse transcriptase human immunodeficiency virus type-1 gene in first-line antiretroviral-infected patients in west sumatra, indonesia [23] avaliação ultra-sonográfica, ecocardiográfica fetal e resultados perinatais em gestantes portadoras do hiv em uso de terapia anti-retroviral ultrasound examination, fetal echocardiography and prenatal outcome in hiv-positive pregnant women under antiretroviral therapy [24] comparison of highly resolved model-based exposure metrics for traffic-related air pollutants to support environmental health studies [25] patient-provider communication styles in hiv treatment programs in bamako, mali: a mixed-methods study to define dimensions and measure patient preferences [26] does first line antiretroviral therapy increase the prevalence of cardiovascular risk factors in indian patients?: a cross sectional study [27] hiv drug resistance following a decade of the free antiretroviral therapy programme in india: a review [28] evolution of patients with aids after cart: clinical and laboratory evolution of patients with aids after 48 weeks of antiretroviral treatment [29] trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary hiv clinic in nairobi, kenya: a 2004–2015 retrospective cohort study [30] human immunodeficiency virus endocrinopathy [31] resistencia a los medicamentos antirretrovirales en pacientes que reciben tratamiento para vih-sida en colombia resistance to antiretrovirals in patients receiving hiv-aids therapy in colombia [32] A Machine Learning Approach for Identifying Amino Acid Signatures in the HIV Env Gene Predictive of Dementia [33] Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure. [34] Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment. [35] Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC [36] Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals [37] The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa [38] The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria. [39] Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons. [40] EFFECT OF COMMUNITY TREATMENT INITIATIVE ON ANTIRETROVIRAL THERAPY UPTAKE AMONG LINKAGE - RESISTANT PLHIV IN NORTHERN NIGERIA. [41] Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART). [42] Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy. [43] Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: Predicted effect of using a single viral load to define efavirenz-based first-line failure [44] Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy [45] HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016 [46] Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda. [47] Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy. [48] The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa [49] Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil [50] Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study. [51] Factors associated with antiretroviral therapy adherence in adults: An integrative review of literature [52] Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review. [53] Optimizing Antiretroviral Therapy in Treatment-Experienced Patients Living with HIV: A Critical Review of Switch and Simplification Strategies. An Opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy. [54] Antiretroviral therapy maintenance among HIV-positive women in Ghana: the influence of poverty [55] A Qualitative Study to Identify Perceptual Barriers to Antiretroviral Therapy (ART) Uptake and Adherence in HIV Positive People from UK Black African and Caribbean Communities. [56] Barriers and facilitators of antiretroviral therapy adherence in rural Eastern province, Zambia: the role of household economic status. [57] "If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. [58] Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study. [59] Assessing the Content Validity of a New Patient-Reported Measure of Barriers to Antiretroviral Therapy Adherence for Electronic Administration in Routine HIV Care: Proposal for a Web-Based Delphi Study. [60] [Comparative study on the effect of highly active antiretroviral therapy (HAART) in patients with HIV infection acquired by blood transfusion and paid plasma donation]. [61] [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin]. [62] High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015. [63] A first-line antiretroviral therapy-resistant HIV patient with rhinoentomophthoromycosis. [64] Large transmission clusters of HIV-1 main genotypes among HIV-1 individuals before antiretroviral therapy in the Hebei province, China. [65] A comparison of adherence to antiretroviral therapy amongst adolescent patients of the Baylor International Pediatric AIDS Initiative Children’s Centers of Excellence before and after attendance at recreational therapy camp [66] DEMOGRAPHIC PROFILE OF HIV-POSITIVE PATIENTS REGISTERED AT ANTIRETROVIRAL THERAPY CENTRE HAYATABAD MEDICAL COMPLEX, PESHAWAR [67] Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. [68] The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events. [69] CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. [70] Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients [71] Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection [72] Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother-to-child transmission services at antenatal care in Zomba District, Malawi. [73] WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients. [74] Convenience without disclosure: A formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania [75] Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019. [76] Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review [77] Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. [78] Utilization of dual contraception method among reproductive age women on antiretroviral therapy in selected public hospitals of Northern Ethiopia. [79] Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. [80] Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention. [81] The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era [82] Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial [83] Is Modern Antiretroviral Therapy Causing Weight Gain? [84] High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites [85] Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy [86] Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy [87] Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor–Based Antiretroviral Therapy [88] CD4+ Cell Count, Viral Load, and Highly Active Antiretroviral Therapy Use Are Independent Predictors of Body Composition Alterations in HIV-Infected Adults: A Longitudinal Study [89] Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia [90] Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy [91] Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe [92] Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy [93] Immune restoration disease after antiretroviral therapy [94] Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006–2011: Findings From Four Sub-Saharan African Countries [95] Strengthening Healthcare Capacity Through a Responsive, Country-Specific, Training Standard: The KITSO AIDS Training Programâs Sup-port of Botswanaâs National Antiretroviral Therapy Rollout [96] Randomized Study of the Safety and Efficacy of Fish Oil (Omega-3 Fatty Acid) Supplementation with Dietary and Exercise Counseling for the Treatment of Antiretroviral Therapy—Associated Hypertriglyceridemia [97] Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe [98] Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies [99] Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007 [100] Long-Term Effectiveness of Highly Active Antiretroviral Therapy on the Survival of Children and Adolescents with HIV Infection: A 10-Year Follow-Up Study [101] Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries